small bowel preparation for capsule endoscopy

Comparison of small bowel preparation for capsule endoscopy with low-volume or minimum-volume polyethylene glycol plus ascorbic acid: a multi-center randomized study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0005347

Enrollment

400

Registered

2020-08-25

Start date

2020-08-24

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1. Group A: standard dose of low-volume Polyethylene glycol with ascorbic acid (Coolprep®, Taejun Co., Seoul, Korea) 2L 2. Group B: standard dose of minimum-volume Polyethylene glycol with asco

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 20-90 years old 2. Subjects who received capsule endoscopy for small bowel evaluation 3. patients who signed the consent

Exclusion criteria

Exclusion criteria: Under 20 or over 90 years old, subjects who had bowel resection, history of gastrointestinal surgery, use of antispasmodic, analgesic or prokinetic agents, diarrhea, thyroid disease, diabetes mellitus, chronic renal failure, known or suspected small bowel obstruction and stricture, and patients who refused to sign the consent

Design outcomes

Primary

Measure	Time frame
degree of bowel preparation (small bowel visualization quality)	—

Secondary

Measure	Time frame
diagnostic yield;Cecal completion rate;small bowel transit time	—

Countries

Korea, Republic of

Contacts

Public ContactSang Pyo Lee

Hallym University Medical Center-Dongtan

Outcome results